Yahr
Impact in
- Neurology top 5%
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Neurofibromatosis and Schwannoma Cases
-
- Neuroscience and Neuropharmacology Research
- Genetic Neurodegenerative Diseases
- Neurotransmitter Receptor Influence on Behavior
Papers in ⓘ
- Neurology 15
- Parkinson's Disease Mechanisms and Treatments 8
- Neurological disorders and treatments 4
- Neuroblastoma Research and Treatments 1
-
- Neurological and metabolic disorders 3
- Co-authors
- Duvoisin Rc (7 shared papers)D M Cowen (1 shared paper)Kabat Ea (2 shared papers)Iván Bódis-Wollner (1 shared paper)J Pecci-Saavedra (1 shared paper)P Pasik (1 shared paper)Tauba Pasik (1 shared paper)Gil’ad N. Cohen (2 shared papers)
- Journals
- PubMed (32 papers)
- Partner nations
- United States
In The Last Decade
Yahr
31 papers receiving 357 citations
Peers
Comparison fields: 5 of 77
- Neurology 241
- Cellular and Molecular Neuroscience 114
- Psychiatry and Mental health 58
- Biological Psychiatry 9
- Rheumatology 38
Countries citing papers authored by Yahr
This map shows the geographic impact of Yahr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yahr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yahr more than expected).
Fields of papers citing papers by Yahr
This network shows the impact of papers produced by Yahr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yahr. The network helps show where Yahr may publish in the future.
Co-authors
The 15 scholars most cited alongside Yahr, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism. | 1968 | 71 |
| 2 | Determination of plasma and cerebrospinal fluid levels of dilantin in the human. | 1960 | 49 |
| 3 | Neurological aspects of neurofibromatosis. | 1981 | 30 |
| 4 | Childhood lupus erythematosus. A clinical and pathological study of the neurological manifestations. | 1960 | 26 |
| 5 | Parkinson's disease and long-term levodopa therapy. | 1987 | 23 |
| 6 | Modification of L-dopa therapy of Parkinsonism by alpha-methyldopa hydrazine (MK-486). | 1971 | 22 |
| 7 | Encephalopathy associated with carcinoma. | 1965 | 21 |
| 8 | Variations in the "on-off" effect. | 1974 | 20 |
| 9 | Serotonin in pallidal neuronal circuits: an immunocytochemical study in monkeys. | 1984 | 18 |
| 10 | Cholinergic and dopaminergic mechanisms in Parkinson's disease after long-term L-DOPA administration. | 1984 | 18 |
| 11 | Nonmotor functions of the basal ganglia. | 1984 | 16 |
| 12 | Parkinson's disease. The L-dopa era. | 1993 | 13 |
| 13 | Neurological diseases with elevation of cerebrospinal fluid gamma globulin: a critical review. | 1962 | 11 |
| 14 | Influenza A virus as a possible cause of postencephalitic Parkinsonism. | 1973 | 10 |
| 15 | R-(-)-deprenyl and parkinsonism. | 1987 | 8 |
| 16 | L-deprenyl, a MAO-B inhibitor, as an adjunct to conventional L-dopa therapy in Parkinson's disease: experience in 200 patients. | 1990 | 8 |
| 17 | Parkinson's disease--overview of its current status. | 1977 | 7 |
| 18 | Sudden onset of involuntary movement disorders with arteriovenous malformations of the basal ganglia. | 1983 | 6 |
| 19 | Pyridoxine, DOPA, and Parkinsonism. | 1972 | 6 |
| 20 | Central neurocytoma: An unusual intraventricular tumor. | 1995 | 6 |
About Yahr
Yahr is a scholar working on Neurology, Endocrinology, Diabetes and Metabolism, Genetics, Clinical Biochemistry and Rheumatology, having authored 32 papers that have together received 419 indexed citations. Recurring topics across this work include Parkinson's Disease Mechanisms and Treatments (8 papers), Neurological disorders and treatments (4 papers), Metabolism and Genetic Disorders (3 papers), Neurological and metabolic disorders (3 papers), Glioma Diagnosis and Treatment (3 papers), Pharmacological Effects and Toxicity Studies (1 paper), Neuroblastoma Research and Treatments (1 paper) and Airway Management and Intubation Techniques (1 paper). The work is most often cited by research in Neurology (241 citations), Cellular and Molecular Neuroscience (114 citations), Psychiatry and Mental health (58 citations), Biological Psychiatry (9 citations) and Rheumatology (38 citations). Yahr has collaborated with scholars based in United States. Frequent co-authors include Duvoisin Rc, D M Cowen, Kabat Ea, Iván Bódis-Wollner, J Pecci-Saavedra, P Pasik, Tauba Pasik, Gil’ad N. Cohen, K Sivakumar and Andreas Plaitakis. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.